Farther Finance Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Buy |
7,775
+7,653
| +6,273% | +$18.4K | ﹤0.01% | 2713 |
|
|
2025
Q1 | $264 | Sell |
122
-10,074
| -99% | -$21.8K | ﹤0.01% | 3900 |
|
|
2024
Q4 | $55.6K | Buy |
10,196
+9,916
| +3,541% | +$54K | ﹤0.01% | 1607 |
|
|
2024
Q3 | $2.33K | Buy |
280
+30
| +12% | +$249 | ﹤0.01% | 2940 |
|
|
2024
Q2 | $1.74K | Buy |
250
+122
| +95% | +$847 | ﹤0.01% | 2851 |
|
|
2024
Q1 | $1.1K | Sell |
128
-93
| -42% | -$800 | ﹤0.01% | 2734 |
|
|
2023
Q4 | $1.45K | Buy |
221
+121
| +121% | +$793 | ﹤0.01% | 2569 |
|
|
2023
Q3 | $1K | Buy |
100
+90
| +900% | +$900 | ﹤0.01% | 2083 |
|
|
2023
Q2 | $124 | Hold |
10
| – | – | ﹤0.01% | 2413 |
|
|
2023
Q1 | $140 | Buy |
+10
| New | +$140 | ﹤0.01% | 2259 |
|